ArticleScientific reports2025
Identifying ferroptosis-related genes in lung adenocarcinoma using random walk with restart in the PPI network.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative analysis and experimental validation of dioxin-interacting genes reveal diagnostic and prognostic biomarkers in lung adenocarcinoma.Clinical and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Lung adenocarcinoma (LUAD), the most common non-small cell lung cancer subtype, often presents with subtle early symptoms leading to delayed diagnosis. Ferroptosis, a cell death process associated with iron metabolism dysregulation, has been linked to cancer onset, progression, and treatment resistance. Thus, identifying ferroptosis-related genes may offer novel insights for LUAD therapy. In this study, we employed the random walk with restart (RWR) algorithm on the LUAD protein-protein interaction (PPI) network to predict ferroptosis-related target genes. Gene set enrichment analysis (GSEA) explored the relationship between XBP1 and ferroptosis, while tumor microenvironment analysis evaluated the correlation between XBP1 expression and immune cell infiltration. External cohorts validation was performed using the GSE118370, GSE68465, and TCGA-LUAD datasets. Our analysis identified XBP1 as a potential ferroptosis-related gene in LUAD. GSEA confirmed a strong association between XBP1 and the ferroptosis process, along with its involvement in the tumor microenvironment, and external cohorts demonstrated its high expression and significant correlation with immune cell infiltration in LUAD tissues. These findings suggest that XBP1 plays a key role in LUAD development and progression, providing new perspectives for precision therapies targeting the ferroptosis pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.